Endocrine Oncology
Bioscientifica Β· United Kingdom
Aims & Scope⦠Inferred from recent articles
This journal focuses on neuroendocrine neoplasms (NENs) and related conditions, including adrenocortical carcinoma, pituitary tumors, and thyroid cancer. It covers the molecular genetics, diagnosis, treatment, and outcomes of these diseases. Research includes hereditary syndromes like multiple endocrine neoplasia (MEN), specific tumor types such as paragangliomas and pancreatic neuroendocrine tumors, and the impact of treatments like mitotane and peptide receptor radionuclide therapy (PRRT). The scope also extends to patient-reported outcomes, treatment-related side effects, and the role of genetic factors in disease development and management.
AI-summarised from recent articles Β· verify on publisher page β
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category β its quartile can differ by discipline.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Endocrine Oncology
Is Endocrine Oncology a predatory journal?
PubScope has no integrity flags on record for Endocrine Oncology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 68/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Endocrine Oncology?
Endocrine Oncology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.397.
Is Endocrine Oncology indexed in Scopus and Web of Science?
Endocrine Oncology is indexed in Scopus, DOAJ.
You May Also Like
See all βData updated: 2026-05-26 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref